logo
Plus   Neg
Share
Email

Brink's Guides FY20 Below Estimates - Quick Facts

While reporting financial results for the fourth quarter on Thursday, The Brink's Co. (BCO) initiated its adjusted earnings and revenue guidance for the full-year 2020, below analysts' estimates.

For fiscal 2020, the company now projects adjusted earnings from continuing operations in a range of $4.30 to $4.50 per share on revenue growth of about 3 percent to $3.775 billion, with organic revenue growth of about 5 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.64 per share on revenue growth of 5.4 percent to $3.90 billion for the year. Analysts' estimates typically exclude special items.

Separately, Brink's announced that its board of directors approved a $250 million share repurchase authorization that expires on December 31, 2021. The authorization replaces the company's previous share repurchase program, which expired December 31, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT